Aneurysms commonly occur in the following arteries
- Aorta or the main artery
- Brain-cerebral aneurysm
- Leg-(popliteal artery aneurysm)
- Intestine(mesenteric artery aneurysm)
- Spleen(splenic artery aneurysm)
What causes an Aneurysm?
The causes of aneurysm can be divided into the following
- Modifiable factors: Smoking, high cholesterol levels and hypertension are some modifiable factors that contribute to the formation of an aneurysm. Therefore, life-style modifications that include diet and regular exercise can reduce the chances of an aneurysm developing
- Non-modifiable factors: Family history of aneurysm
- Pregnancy: Pregnancy can lead to formation and rupture of the splenic artery aneurysm
To have a better understanding of the relationship between genetics and aneurysms, we can divide aneurysms to intracranial and abdominal aneurysm.
Intracranial aneurysm: Stroke is the outcome of intracranial aneurysm. Though there have been studies that correlated heredity with stroke, these studies relied on data collected by surveys, thereby failing to distinguish ischemic and hemorrhagic stroke. Framingham investigators investigated family history as a risk factor and concluded that targeting stroke prevention in individuals with parental history of stroke is important. Please see their finding hereunder:
Table: Data of relationship between genetics and stroke from Framingham Study
Abdominal aortic aneurysm (AAA)
Owing to the heterogeneity of aorta, the prevalence of abdominal aorta aneurysm is at least nine times higher than that in the thoracic section of the aorta. It typically affects males > 65 years.
In a recent animal study (2013), Golledge and Kuivaniemi identified genetic markers that increase the risk of abdominal aortic aneurysm. They are believed to be located within genes for DAB2 interacting protein (DAB2IP) and low density lipoprotein receptor-related protein 1 (LRP1).
In an early study, Johansen and Koepsel studied the relationship between genetics and AAA. They divided the subjects into twp groups:
Group1: 250 AAA probands of whom approximately 19% had a first-degree relative of history
Group2 (Control): 250 atherosclerotic occlusive diseases (AOD) with only 2% patients were relative with AAA.
A 12-fold increase in risk for the relatives of AAA probands was noted, thus relatives of AAA must be screened to ensure early diagnosis of AAA and thereby initiation of treatment.
Managing Aneurysm
The most effective mechanism of managing aneurysm is surgical treatments. Though these yield excellent results, there is a need to develop non-surgical methods. Major discoveries involving the genetic factors that lead to the development of aneurysm is needed for development of targeted drug.